Abbott Laboratories (ABT.MX)
Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
At close: 12:10PM CST
Currency in MXN
Valuation measures4
| Market cap (intra-day) | 3.34T |
| Enterprise value | 3.48T |
| Trailing P/E | 30.28 |
| Forward P/E | 20.92 |
| PEG ratio (5-yr expected) | 3.91 |
| Price/sales (ttm) | 4.21 |
| Price/book (mrq) | 4.36 |
| Enterprise value/revenue | 4.71 |
| Enterprise value/EBITDA | 18.26 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.74 |
| 52-week change 3 | -3.81% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 2,049.00 |
| 52-week low 3 | 1,600.00 |
| 50-day moving average 3 | 1,820.88 |
| 200-day moving average 3 | 1,828.33 |
Share statistics
| Avg vol (3-month) 3 | 114 |
| Avg vol (10-day) 3 | 368 |
| Shares outstanding 5 | 1.74B |
| Implied shares outstanding 6 | 1.87B |
| Float 8 | 1.73B |
| % held by insiders 1 | 0.53% |
| % held by institutions 1 | 77.02% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 40.66 |
| Forward annual dividend yield 4 | 2.28% |
| Trailing annual dividend rate 3 | 2.12 |
| Trailing annual dividend yield 3 | 0.12% |
| 5-year average dividend yield 4 | 1.61 |
| Payout ratio 4 | 64.80% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 15 Jul 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 13.96% |
| Operating margin (ttm) | 15.40% |
Management effectiveness
| Return on assets (ttm) | 6.09% |
| Return on equity (ttm) | 14.76% |
Income statement
| Revenue (ttm) | 40.33B |
| Revenue per share (ttm) | 23.18 |
| Quarterly revenue growth (yoy) | 2.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 10.37B |
| Net income avi to common (ttm) | 5.61B |
| Diluted EPS (ttm) | 58.80 |
| Quarterly earnings growth (yoy) | -7.10% |
Balance sheet
| Total cash (mrq) | 6.65B |
| Total cash per share (mrq) | 3.82 |
| Total debt (mrq) | 14.71B |
| Total debt/equity (mrq) | 37.66% |
| Current ratio (mrq) | 1.60 |
| Book value per share (mrq) | 22.31 |
Cash flow statement
| Operating cash flow (ttm) | 7.14B |
| Levered free cash flow (ttm) | 4.61B |
© 2024 Yahoo. All rights reserved.